Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02298842 · ClinicalTrials.gov registry record · NA
In Vitro Study of Platelets Collected on Trima Accel System and Stored in InterSol Solution
A NA study, sponsored by Terumo BCT.
- Completed
- Registry status
- NA
- Development phase
- 87
- Enrollment target
NCT02298842 is a NA study that has completed, run by Terumo BCT. The registered enrollment target is 87 participants.
The verdict
NCT02298842, a NA study, has completed, sponsored by Terumo BCT.
- COMPLETED
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
Study Summary
This study sought to verify that the in vitro quality (functional assays) of platelets collected on the Trima Accel system, Version 6.4, diluted in InterSol Solution, and stored for 1, 5, and 7 days meet FDA requirements.
Interventions
- DEVICE Platelets stored in InterSol
- DEVICE Platelets stored in Plasma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2015-11-05 |
| Est. Completion | 2016-05-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02298842
The ClinicalTrials.gov registry entry for NCT02298842 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Terumo BCT, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Platelets stored in InterSol is the first listed.
NCT02298842 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02298842 about?
NCT02298842 is a clinical study titled "In Vitro Study of Platelets Collected on Trima Accel System and Stored in InterSol Solution". This study sought to verify that the in vitro quality (functional assays) of platelets collected on the Trima Accel system, Version 6.4, diluted in InterSol Solution, and stored for 1, 5, and 7 days meet FDA requirements.
What is the current status of trial NCT02298842?
This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2015-11-05. Estimated completion is 2016-05-12.
What interventions are being tested in trial NCT02298842?
The interventions under investigation include: Platelets stored in InterSol (DEVICE), Platelets stored in Plasma (DEVICE).
Who is sponsoring clinical trial NCT02298842?
This trial is sponsored by Terumo BCT, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.